drugset / Trial / NCT00955006
Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of the study is to determine the safety of mucosal immune responses to a DNA HIV vaccine followed by an adenoviral vector HIV vaccine in HIV uninfected adults.
Timeline
- Start
- 2011-05
- Primary completion
- 2013-09
- Completion
- 2017-11-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VRC-HIVADV014-00-VP | Vaccine | — | Intramuscular |
| Subject | VRC-HIVDNA016-00-VP | Vaccine | — | Intramuscular |